Sylvia Garza-Manero

Dr. Sylvia Garza-Manero

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 May 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
BBBrandon Bustos-Garcia
Brandon Bustos-Garcia
SGSylvia Garza-Manero
Sylvia Garza-Manero
NCNallely Cano-Dominguez
Nallely Cano-Dominguez
DLDulce López-Sánchez
Dulce López-Sánchez
GOGonzalo Salgado-Montes de Oca
Gonzalo Salgado-Montes de Oca
JVJulian Valdes
Julian Valdes
Massive testing is a cornerstone in efforts to effectively track infections and stop COVID-19 transmission, including places with good vaccination coverage. However, SARS-CoV-2 testing by RT-qPCR requires specialized personnel, protection equipment, commercial kits, and dedicated facilities, which represent significant challenges for massive testing in resource-limited settings. It is therefore important to develop testing protocols that are inexpensive, fast, and sufficiently sensitive. Here, we optimized the composition of a buffer (PKTP), containing a protease, a detergent, and an RNase inhibitor, which is compatible with the RT-qPCR chemistry, allowing for direct SARS-CoV-2 detection from saliva without extracting RNA. PKTP is compatible with heat inactivation, reducing the biohazard risk of handling samples. We assessed the PKTP buffer performance in comparison to the RNA-extraction-based protocol of the US Centers for Disease Control and Prevention in saliva samples from 70 COVID-19 patients finding a good sensitivity (85.7% for the N1 and 87.1% for the N2 target) and correlations (R = 0.77, p < 0.001 for N1, and R = 0.78, p < 0.001 for N2). We also propose an auto-collection protocol for saliva samples and a multiplex reaction to minimize the PCR reaction number per patient and further reduce costs and processing time of several samples, while maintaining diagnostic standards in favor of massive testing.

25 April 2024 in Genes
Verified
Journal Article
Open access
PDF file
CPCarlos Alberto Peralta-Alvarez
Carlos Alberto Peralta-Alvarez
HNHober Nuñez
Hober Nuñez
ÁCÁngel Josué Cerecedo-Castillo
Ángel Josué Cerecedo-Castillo
APAugusto César Poot-Hernández
Augusto César Poot-Hernández
GTGustavo Tapia-Urzúa
Gustavo Tapia-Urzúa
FRFélix Recillas-Targa
Félix Recillas-Targa
Recent evidence suggests that human gene promoters display gene expression regulatory mechanisms beyond the typical single gene local transcription modulation. In mammalian genomes, genes with an associated bidirectional promoter are abundant; bidirectional promoter architecture serves as a regulatory hub for a gene pair expression. However, it has been suggested that its contribution to transcriptional regulation might exceed local transcription initiation modulation. Despite their abundance, the functional consequences of bidirectional promoter architecture remain largely unexplored. This work studies the long-range gene expression regulatory role of a long non-coding RNA gene promoter using chromosome conformation capture methods. We found that this particular bidirectional promoter contributes to distal gene expression regulation in a target-specific manner by establishing promoter–promoter interactions. In particular, we validated that the promoter–promoter interactions of this regulatory element with the promoter of distal gene BBX contribute to modulating the transcription rate of this gene; removing the bidirectional promoter from its genomic context leads to a rearrangement of BBX promoter–enhancer interactions and to increased gene expression. Moreover, long-range regulatory functionality is not directly dependent on its associated non-coding gene pair expression levels.

25 April 2025
Verified
Book Chapter
Open access
PDF file
SGSylvia Garza-Manero
Sylvia Garza-Manero
HNHober Nuñez
Hober Nuñez
GTGustavo Tapia-Urzúa
Gustavo Tapia-Urzúa
FRFélix Recillas-Targa
Félix Recillas-Targa
Genetic sex determination required the specialization of an ancestral autosome pair into sexual chromosomes. This evolutionary trajectory involves recombination suppression in the sexual pair and degeneration of one chromosome. In species with a male XY heterogametic system, the Y chromosome is highly degenerated, creating a difference in the dosage of X-linked genes between females and males. To overcome this difference, one X chromosome is transcriptionally silenced in female mammals. Conversely, genes on the single-male X chromosome of lizards and the fruit fly are overexpressed, reaching the transcriptional output produced by two X chromosomes in females. Despite promoting opposite effects on transcription, these dosage compensation mechanisms share relevant features, including the modification of the chromatin landscape and three-dimensional conformation orchestrated, at least in part, by long non-coding RNAs transcribed from the target X. In this chapter, we describe the mechanisms of X chromosome dosage compensation in eutherians, marsupials, Drosophila, and a lizard. We focus on the leading role of the respective long non-coding RNA, XIST in eutherians, RSX in marsupials, roX1 and roX2 in the fruit fly, and the recently described MAYEX in lizards, in the ambitious task of equalizing the transcriptional output of X-linked genes between females and males.